Grow Therapy
We're Hiring!
Grow Therapy Company Growth, Stability & Outlook
What People Are Saying About Grow Therapy
-
Investor Backing & Capital Strength: Recent funding includes a $150M Series D led by prominent investors, bringing total capital to roughly $328M and enabling platform expansion.
-
Strong Revenue Growth: Public signals cite higher visit volumes (7 million in 2025 and 10 million lifetime), with trade press reporting a billion‑dollar run‑rate that has not been independently verified.
-
Market Expansion: Distribution is broadening through 125+ insurance partners and deeper moves into employers and health systems, with an employer‑focused benefit slated for 2026.
